Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash and Cash Equivalents	$ 3,899,152	$ 4,754,597
Restricted Cash	126,966	129,778
Accounts Receivable, Net	203,919	281,049
Inventory, Net	490,388	324,515
Other Current Assets	558,395	435,580
Total Current Assets	5,278,820	5,925,520
Property and Equipment, Net	1,071,249	891,187
Other Assets	252,213	444,723
Total Assets	6,602,282	7,261,430
CURRENT LIABILITIES
Accounts and Other Payables	1,101,491	1,110,087
Short Term Debt	250,454	348,771
Current Portion of Long-Term Debt	125,227
Total Current Liabilities	1,477,172	1,458,858
Long-term Debt	480,036
Total Liabilities	1,957,208	1,458,858
STOCKHOLDERS’ EQUITY
Preferred Stock, value
Common Stock, $0.00001 par value; 37,500,000 shares authorized; 16,169,891 and 16,169,891 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	162	162
Additional Paid-In Capital	54,061,943	54,065,633
Non-controlling Interest	(109,860)	(99,048)
Accumulated Other Comprehensive Loss	(257,178)	(222,380)
Accumulated Deficit	(49,049,993)	(47,941,796)
Total Stockholders’ Equity (Deficit)	4,645,074	5,802,572
Total Liabilities and Stockholders’ Equity	6,602,282	7,261,430
Series B Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock, value